INTRODUCTION Selecting PLGA for peptide, protein, and nucleic acid delivery requires choosing the right polymer chemistry, molecular weight, and end-group […]
Selecting PLGA for Peptide, Protein, and Nucleic Acid (mRNA/siRNA) Delivery Read More »
Introduction PLGA Characterization Methods are essential to ensure the performance, purity, safety, and reproducibility of Poly(lactic-co-glycolic acid)—one of the most
INTRODUCTION At ResolveMass Laboratories Inc., we understand that a robust PLGA Degradation Profile is fundamental to the success of any
INTRODUCTION PLGA Microsphere Formulation is the cornerstone of controlled-release drug delivery because particle engineering enables precise control over degradation, release
INTRODUCTION PLGA Residual Solvents are trace organic chemicals remaining after polymer synthesis, and they significantly influence the safety, quality, performance,
Introduction Regulatory requirements for PLGA excipient qualification have become stricter under the US FDA, EMA, and global ICH frameworks. Because
Summary Introduction: The Science of Custom PLGA Release Control At ResolveMass Laboratories Inc., Custom PLGA Release Control represents a full
Introduction This PLGA Microsphere Case Study provides a detailed look at the formulation design and process development behind a generic
Summary (Key Takeaways) Introduction Scaling PLGA (Poly(lactic-co-glycolic acid)) from small batches to multi-kg output is a major milestone for any
Introduction: Why PLGA Microparticles Are Reshaping Oncology Formulation In modern cancer treatment, PLGA Oncology Formulation platforms are transforming how drugs
